InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the detailed record of transactions filed by Duvall Diantha, 首席财务官. Insider active across 2 companies, notably Genocea Biosciences, INC.. Cumulatively, 5 reports have been recorded. Breakdown: 0 buy · 3 sells. Total volume traded: €3k. History available since 15 March 2022. The latest transaction was disclosed on 2 June 2022 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Duvall Diantha is Directeur Financier at Genocea Biosciences, INC. and CURIS INC. She has 5 filings in total, and across the 5 recent filings we hold, sell volume is EUR 2912 between 2022-03-17 and 2026-03-23, with the dominant transaction nature listed as Cession.